NCT03847766Completed
Follow-up Using Patient-Reported Outcome (PRO) Measures in Patients With Chronic Kidney Disease
Tele Follow-up Using Patient-reported Outcomes (PRO) Measures in Patients With Chronic Kidney Disease - the PROKID Study
Source: ClinicalTrials.gov · Last updated 22 Dec 2023
Brief summary (registry, in English)
This randomized controlled trial (RCT) will evaluate if PRO-based follow-up is at least as effective as usual outpatient follow-up in managing decline in renal function and maintaining patients' quality of life. Furthermore, we intend to characterize the target patient group that is suitable for PRO-based follow up in a group of patients suffering from renal insufficiency.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 152 (actual)
- First submitted
- 23 Jan 2019
- Start date
- 3 Dec 2018
- Primary completion date
- 15 Dec 2023
- Lead sponsor
- University of Aarhus
- Diseases
- Chronic kidney disease
- NCT number
- NCT03847766
What you commit to
- Study type: Interventional
- Participants enrolled: 152
- From 3 Dec 2018 to the primary completion date, 15 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have received (or have a scheduled date to receive) a kidney transplant
Other illness
- A terminal illness that, in the opinion of the consultant assessing eligibility, is likely to lead to the death of the patient within 6 months of starting participation in the study
Lab values
- Patients with an eGFR \> 39mL/min 1.73m2 at their first visit at the hospital
- Patients receiving chemotherapy, with end stage Chronic Obstructive Lung disease, or with heart failure with Ejection Fraction (EF)\< 15 %.
- A projected risk of progression to end-stage renal failure within 6 months, determined from albumin/creatinine ratio
Other
- Patients unwilling to participate in PRO-based follow-up
- Patients who, in the opinion of the consenting professional, cannot speak, read or write Danish sufficiently well to complete the PRO questionnaire unaided
- Patients with hearing disabilities
Who the study is looking for
- Referred to the renal care services at Aarhus University Hospital or Regional Hospital Central Jutland, Viborg
- Estimated Glomerular Filtration Rate (eGFR) between 10-39 mL/min 1.73m2.
- Aged ≥18 years old
- Ability to provide fully informed written consent for participation in the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Birgith Engelst Grove Coordinator of this site? Confirm its status | Herning | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.